[5]Vasir Jk ,Labhasetwar v.Targeted drug deriver/in∞ncer therapy.Technol Cancer Res Treat,2005,4(4):363—374.
[6]Mitra S,Gaur U,Ghosh PC,et a1.Tumor targeted defivery of encapsulated dextran—doxorubidn conjugate using ehitosaunanoparticles as CalTieL J Control Release,2001。74(1/3):317—323.
[7]Le Garrec D,God S,Luo L,et a1.Poly(N—vinylpyrrolidone)-bloekpoly(D'L—lactide)as a new polymeric solubilizer for hydrophobic anticancer drugs:in vitro and in vivo eva luation.J Control Release。2004,99(1):83—101.
[8]Ma CB,Liu XY.Chang J,et a1.Study of targeting and conuoHed release behavior of 5.Fluorouracii—loaded PLA ultramicron on the treatment of human gastric tumor xenograft.Polymer Bulletin,2005。(6):90一94.(in Chinese)
[9]Liu Y,Miyoshi H,Nakamura M,et a1.Nanomedicine for drug delivery and imaging:a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.Int J Cancer,2007,120(12):2527—2537.
[10]AImeida AJ,Souto E.Sofid lipid nanoparticles嬲a drug deHvery system for peptides and proteins.Adv Drug Defiv Rev,2007,59(6):478.490.
[12]Hosokawa S,Tagawa T,Niki H,et a1.Efficacy of immunoliposomes on cancer model s in a cell-surface-antigen-density—dependent mannm. rJ Cancer,2003。89(8):1545—1551.
[13]Farokhzad OC,Cheng J,Teply BA,et a1.Targeted nanoparficleaptamer bioconjugates for cancer chemotherapy in vivo.Proc Nail Acad Sci U S A,2006,103(16):6315-6320.